Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “derivative”

1,342 pharma patents match "derivative" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,342
Index total 30,257
Page 14 / 56

Quick answer

This filtered view shows 1,342 pharmaceutical patents matching "derivative" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,342 results for “derivative” · 30,257 patents in full index Clear search

  1. US 10344033

    2-aminoquinazoline derivatives as P70S6 kinase inhibitors

    SENTINEL ONCOLOGY LIMITED · Granted Jul 9, 2019 · Expires Jul 4, 2039

    granted

  2. US 10335402

    Sulfonyl piperidine derivatives and their use for treating prokineticin mediated gastrointestinal disorders

    Takeda Pharmaceutical Company Limited · Granted Jul 2, 2019 · Expires Jun 27, 2039

    granted

  3. US 10329259

    Pyrazole derivatives and their use as cannabinoid receptor mediators

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 25, 2019 · Expires Jun 20, 2039

    granted

  4. US 10328161

    Luciferin derivatives from bicyclic reactants and aminothiol derivatives and methods of use thereof

    The Regents of the University of California · Granted Jun 25, 2019 · Expires Jun 20, 2039

    granted

  5. US 10328089

    Fumagillol derivatives

    Takeda Pharmaceutical Company Limited · Granted Jun 25, 2019 · Expires Jun 20, 2039

    granted

  6. US 10323027

    2,3-dihydro-4H-1,3-benzoxazin-4-one derivatives as modulators of cholinergic muscarinic M1 receptor

    Takeda Pharmaceutical Company Limited · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted

  7. US 10322107

    N-methyl-N-(1-phenyl-2-(1-pyrrolidinyl)ethyl)-2-aminophenylacetamide derivatives agonists for the kappa opioid receptor

    Nektar Therapeutics · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted

  8. US 10307414

    Pyridinyl and fused pyridinyl triazolone derivatives

    Takeda Pharmaceutical Company Limited · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  9. US 10308617

    Triazole benzamide derivatives and the compositions and methods of treatment regarding the same

    AN2H DISCOVERY LIMITED · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  10. US 10308635

    1-sulfonyl piperidine derivatives as modulators of prokineticin receptors

    Takeda Pharmaceutical Company Limited · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  11. US 10300072

    Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities

    Almirall, S.A. · Granted May 28, 2019 · Expires May 23, 2039

    granted

  12. US 10287284

    Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof

    VTV THERAPEUTICS LLC · Granted May 14, 2019 · Expires May 9, 2039

    granted

  13. US 10287297

    Epoxyazulene derivatives useful for treating cancer and diabetes

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 14, 2019 · Expires May 9, 2039

    granted

  14. US 10287262

    Eicosanoid derivatives

    The Board of Regents of the University of Texas System · Granted May 14, 2019 · Expires May 9, 2039

    granted

  15. US 10266496

    Carboxy substituted (hetero) aromatic ring derivatives and preparation method and uses thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  16. US 10266488

    4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase

    THE UNITED STATES OF AMERICA, DEPARTMENT OF HEALTH AND HUMAN SERVICES · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  17. US 10258701

    Labeled evans blue dye derivative for in vivo serum albumin labeling

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  18. US 10258699

    Angiopep and derivatives thereof for imaging amyloids

    UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  19. US 10259846

    Bouvardin derivatives and therapeutic uses thereof

    The Regents of the University of Colorado · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  20. US 10246471

    ETP derivatives

    The Regents of the University of California · Granted Apr 2, 2019 · Expires Mar 28, 2039

    granted

  21. US 10239837

    Piperidine derivatives as HDAC1/2 inhibitors

    Regenacy Pharmaceuticals, Inc. · Granted Mar 26, 2019 · Expires Mar 21, 2039

    granted

  22. US 10239832

    N-(1-hydroxy-3-(pyrrolidinyl)propan-2-yl)pyrrolidine-3-carboxamide derivatives as glucosylceramide synthase inhibitors

    BIOMARIN PHARMACEUTICAL INC. · Granted Mar 26, 2019 · Expires Mar 21, 2039

    granted

  23. US 10226452

    Benzoxazolone derivatives as acid ceramidase inhibitors, and their use as medicaments

    The Regents of the University of California · Granted Mar 12, 2019 · Expires Mar 7, 2039

    granted

  24. US 10227362

    Anti-pulmonary tuberculosis nitroimidazole derivative

    Medshine Discovery Inc. · Granted Mar 12, 2019 · Expires Mar 7, 2039

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.